¥ 4281
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Decent dividends
About
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is overpriced on P/E, of fair value o
Target Price
The average target price of 4502.T is 4998 and suggests 18% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
